Correlation Between 17298CHT8 and Frequency Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 17298CHT8 and Frequency Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 17298CHT8 and Frequency Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between US17298CHT80 and Frequency Therapeutics, you can compare the effects of market volatilities on 17298CHT8 and Frequency Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 17298CHT8 with a short position of Frequency Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 17298CHT8 and Frequency Therapeutics.

Diversification Opportunities for 17298CHT8 and Frequency Therapeutics

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between 17298CHT8 and Frequency is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding US17298CHT80 and Frequency Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Frequency Therapeutics and 17298CHT8 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US17298CHT80 are associated (or correlated) with Frequency Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Frequency Therapeutics has no effect on the direction of 17298CHT8 i.e., 17298CHT8 and Frequency Therapeutics go up and down completely randomly.

Pair Corralation between 17298CHT8 and Frequency Therapeutics

Assuming the 90 days trading horizon US17298CHT80 is expected to generate 0.36 times more return on investment than Frequency Therapeutics. However, US17298CHT80 is 2.76 times less risky than Frequency Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Frequency Therapeutics is currently generating about -0.18 per unit of risk. If you would invest  8,208  in US17298CHT80 on October 22, 2024 and sell it today you would earn a total of  52.00  from holding US17298CHT80 or generate 0.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy21.05%
ValuesDaily Returns

US17298CHT80  vs.  Frequency Therapeutics

 Performance 
       Timeline  
US17298CHT80 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in US17298CHT80 are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 17298CHT8 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Frequency Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Frequency Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

17298CHT8 and Frequency Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 17298CHT8 and Frequency Therapeutics

The main advantage of trading using opposite 17298CHT8 and Frequency Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 17298CHT8 position performs unexpectedly, Frequency Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will offset losses from the drop in Frequency Therapeutics' long position.
The idea behind US17298CHT80 and Frequency Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets